GO
Loading...

The biotech parade

Wednesday, 9 Apr 2014 | 12:27 PM ET

CNBC's Meg Tirrell provides insight on the increase in biotech IPOs, and what to expect from both Cerulean Pharma & Adamas Pharmaceuticals ahead of their IPO pricing Wednesday night.